🇺🇸 FDA

Intelligence · Clinical Pipeline

Takeda Pipeline

All ClinicalTrials.gov programs at Takeda — phase, modality, and trial IDs.

Programs
335

Quick answer

Takeda has 335 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. Immune Globulin Intravenous (Human), 10% Triple Virally Reduced Solution

    Takeda

    Immune Thrombocytopenic Purpura (ITP)

    phase 2 small molecule completed

    1 trial

  2. Ixazomib

    Takeda

    Mantle Cell Lymphoma

    phase 2 small molecule active

    2 trials

  3. Ixazomib

    Takeda

    Myeloid Hematologic Malignancy

    phase 2 small molecule completed

    1 trial

  4. Ixazomib

    Takeda

    Leukemia

    phase 2 small molecule terminated

    1 trial

  5. Ixazomib

    Takeda

    ALL, Childhood

    phase 2 small molecule active

    1 trial

  6. Ixazomib

    Takeda

    Multiple Myeloma

    phase 2 small molecule completed

    15 trials

  7. Ixazomib

    Takeda

    Newly Diagnosed Multiple Myeloma

    phase 2 small molecule terminated

    1 trial

  8. Ixazomib

    Takeda

    Triple-Negative Breast Cancer

    phase 2 small molecule terminated

    1 trial

  9. Ixazomib

    Takeda

    Smoldering Multiple Myeloma

    phase 2 small molecule completed

    1 trial

  10. Ixazomib

    Takeda

    Relapsed/Refractory Multiple Myeloma

    phase 2 small molecule terminated

    1 trial

  11. Ixazomib 1 MG

    Takeda

    Human Immunodeficiency Virus (HIV)

    phase 2 small molecule completed

    1 trial

  12. Ixazomib/Pomalidomide/Dexamethasone

    Takeda

    Multiple Myeloma

    phase 2 small molecule terminated

    1 trial

  13. Jakavi 10 mg tablets, Jakavi 10 mg tablets, Jakavi 20 mg tablets, Jakavi 5 mg tablets, elritercept, Jakavi 20 mg tablets, Jakavi 20 mg tablets, Jakavi 10 mg tablets, Jakavi 5 mg tablets, Jakavi 5 mg tablets

    Takeda

    Myelofibrosis

    phase 2 small molecule active

    1 trial

  14. Lansoprazole

    Takeda

    Esophagitis

    phase 2 small molecule completed

    1 trial

  15. Lanthanum carbonate

    Takeda

    Chronic Kidney Disease

    phase 2 small molecule completed

    2 trials

  16. Lapaquistat acetate and fenofibrate

    Takeda

    Hyperlipidemias

    phase 2 small molecule completed

    1 trial

  17. Lenalidomide

    Takeda

    Myeloma, Multiple

    phase 2 small molecule active

    1 trial

  18. Leuprorelin

    Takeda

    Prostatic Neoplasms

    phase 2 small molecule completed

    1 trial

  19. Leuprorelin (GF)

    Takeda

    Uterine Fibroids

    phase 2 small molecule completed

    1 trial

  20. Levothyroxine sodium new formulation

    Takeda

    Hypothyroidism

    phase 2 small molecule completed

    1 trial

  21. Lifitegrast

    Takeda

    Dry Eye

    phase 2 small molecule completed

    1 trial

  22. Lifitegrast

    Takeda

    Allergic Conjunctivitis

    phase 2 small molecule completed

    1 trial

  23. Lubiprostone

    Takeda

    Irritable Bowel Syndrome

    phase 2 small molecule terminated

    3 trials

  24. MCC-135

    Takeda

    Congestive Heart Failure

    phase 2 small molecule completed

    1 trial

  25. MLN0264

    Takeda

    Pancreatic Adenocarcinoma

    phase 2 small molecule terminated

    1 trial

  26. MLN0264

    Takeda

    Adenocarcinoma of the Stomach

    phase 2 small molecule terminated

    1 trial

  27. MLN1202

    Takeda

    Atherosclerotic Cardiovascular Disease

    phase 2 small molecule terminated

    1 trial

  28. MLN1202 Placebo

    Takeda

    Diabetic Nephropathy

    phase 2 small molecule terminated

    1 trial

  29. Maribavir

    Takeda

    Cytomegalovirus Infection

    phase 2 small molecule completed

    1 trial

  30. Melphalan

    Takeda

    Multiple Myeloma

    phase 2 small molecule completed

    1 trial

  31. Methylphenidate + SPD503 (Guanfacine hydrochloride)

    Takeda

    Attention Deficit Disorder With Hyperactivity

    phase 2 small molecule completed

    1 trial

  32. Mezagitamab

    Takeda

    Relapsed/Refractory

    phase 2 small molecule completed

    1 trial

  33. Mifamurtide

    Takeda

    Osteosarcoma

    phase 2 small molecule terminated

    1 trial

  34. Multivalent recombinant OspA Lyme Borreliosis Vaccine

    Takeda

    Prophylaxis of Lyme Borreliosis

    phase 2 mab completed

    1 trial

  35. NDI-034858

    Takeda

    Psoriatic Arthritis

    phase 2 small molecule completed

    1 trial

  36. NDI-034858 study drug

    Takeda

    Moderate to Severe Plaque Psoriasis

    phase 2 small molecule completed

    1 trial

  37. NPS 1776 (800 mg)

    Takeda

    Migraine Headache

    phase 2 small molecule completed

    1 trial

  38. NPSP795

    Takeda

    Autosomal Dominant Hypocalcemia (ADH)

    phase 2 small molecule completed

    1 trial

  39. Namilumab

    Takeda

    Rheumatoid Arthritis

    phase 2 small molecule completed

    2 trials

  40. Namilumab

    Takeda

    Plaque Psoriasis

    phase 2 small molecule completed

    1 trial

  41. Ninlaro

    Takeda

    Immune Thrombocytopenia

    phase 2 small molecule terminated

    1 trial

  42. Niraparib

    Takeda

    Efficacy

    phase 2 small molecule active

    1 trial

  43. Niraparib

    Takeda

    Ovarian Cancer

    phase 2 small molecule completed

    2 trials

  44. Niraparib-Bevacizumab

    Takeda

    Platinum-sensitive Recurrent Ovarian Cancer Patients Previously Treated With a PARP Inhibitor

    phase 2 small molecule active

    1 trial

  45. Nivolumab

    Takeda

    Relapsed Multiple Myeloma

    phase 2 small molecule terminated

    1 trial

  46. NoV GI.1/GII.4 Bivalent VLP Vaccine

    Takeda

    Norovirus

    phase 2 mab completed

    1 trial

  47. NoV Placebo-matching Saline

    Takeda

    Healthy Volunteers

    phase 2 mab completed

    1 trial

  48. NoV Vaccine

    Takeda

    Healthy Volunteers

    phase 2 mab completed

    1 trial

Frequently asked questions

How many pipeline programs does Takeda have?

335 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.